Library Header Image
LSE Research Online LSE Library Services

Items where Subject is "R Medicine > RM Therapeutics. Pharmacology"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: A | B | C | D | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W
Number of items at this level: 88.


Almond, Stephen and O'Donnell, Owen (2000) Cost analysis of the treatment of schizophrenia in the UK: a a simulation model comparing olanzapine, risperidone and haloperidol. PharmacoEconomics, 17 (4). pp. 383-389. ISSN 1170-7690


Brogan, David and Mossialos, Elias (2013) Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model. Globalization and Health, 9 (58). ISSN 1744-8603

Brown, Sally (2014) Book review: The bitterest pills: the troubling story of antipsychotic drugs by Joanna Moncrieff. LSE Review of Books (21 Jan 2014). Blog Entry.

Buskens, Erik and Heeg, Bart M and Knapp, Martin and van Aalast, Gerda and Dries, Pieter J T and de Haan, Lieuwe and van Hout, Ben A (2005) Modelling the treated course of schizophrenia: development of a discrete event simulation model. PharmacoEconomics, 23 (s1). pp. 17-33. ISSN 1170-7690


Campbell, Catherine and Foulis, C. (2004) Creating contexts for effective home-based care of people living with HIV/AIDS. Curationis, 27 (3). pp. 5-14. ISSN 0379-8577

Cornford, Tony (2017) The digital future beyond the pill. Delivering Digital Drugs (10 May 2017). Blog.

Costa-Font, Joan and McDaid, David (2006) Pharmaceutical policy reform in Spain. Eurohealth, 12 (4). pp. 14-17. ISSN 1356-1030

Costa-i-Font, Joan (2015) Parallel trade in medicinal drugs is putting the welfare of EU patients at risk. LSE European Politics and Policy (EUROPP) Blog (20 Mar 2015). Blog Entry.

Coulter, Steve (2014) The war over drugs: what’s at stake? LSE New European Trade Unions (03 Jun 2014). Blog.


Dickson, Jane (2016) $1 million for a drug used once. Delivering Digital Drugs (10 May 2016). Blog.

Dickson, Jane (2015) Enduring and emerging challenges of informed consent. Delivering Digital Drugs (13 Mar 2015). Blog.

Dickson, Jane (2015) Personalized medicine: a podcast. Delivering Digital Drugs (13 Mar 2015). Blog.

Dickson, Jane (2015) Stratified medicine in 2015 – Leeds Christmas lecture. Delivering Digital Drugs (19 Dec 2015). Blog.

Dickson, Jane (2017) Vocal biomarkers: diagnostics through human voice. Delivering Digital Drugs (17 Feb 2017). Blog.

Dickson, Jane (2017) Warfarin history timeline. Delivering Digital Drugs (15 May 2017). Blog.

Dickson, Jane (2015) A decision support tool for warfarin prescribing. Delivering Digital Drugs (13 Feb 2015). Blog.

Duggan, Andy and Warner, Juliet and Knapp, Martin and Kerwin, Robert (2003) Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. British Journal of Psychiatry, 182 (6). pp. 505-508. ISSN 0007-1250


Feliu-Soler, Albert and Borràs, Xavier and Peñarrubia-María, María T. and Rozadilla-Sacanell, Antoni and D’Amico, Francesco and Moss-Morris, Rona and Howard, Matthew A. and Fayed, Nicolás and Soriano-Mas, Carles and Puebla-Guedea, Marta and Serrano-Blanco, Antoni and Pérez-Aranda, Adrián and Tuccillo, Raffaele and Luciano, Juan V. (2016) Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). BMC Complementary and Alternative Medicine, 16 (1). ISSN 1472-6882

Fernández, José-Luis and Montgomery, Stuart and Francois, Clément (2005) Evaluation of the cost effectiveness of Escitalopram versus Venlafaxine XR in major depressive disorder. PharmacoEconomics, 23 (2). pp. 155-167. ISSN 1170-7690


Ghabri, Salah and Stevenson, Matt and Möller, Jörgen and Caro, J. Jaime (2018) Trusting the results of model-based economic analyses: is there a pragmatic validation solution? PharmacoEconomics. ISSN 1170-7690

Gill, Jennifer and Kanavos, Panos and d'Angela, Daniela and Berger, Karin and Dank, Magdolna and Duncombe, Robert and Fink-Wagner, Antje and Hutton, John and Kossler, Ingrid and Podrazilova, Katerina and Thomas, Michael (2018) RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap. . London School of Economics, London, UK.

Greenan, Caroline and Murphy, Lynn and Yu, Ly-Mee and Kehoe, Patrick G. and Coulthard, Elizabeth and Bath, Philip and Stewart, Robert and Jones, Rob and Corbett, Anne and Thomas, Alan and Connelly, Peter and Arrojo, Frank and Canning, Rachel and Wallach, Sylvia and Henderson, Catherine and McGuinness, Bernadette and O’Sullivan, Mike and Holmes, Clive and Knapp, Martin and Ballard, Clive and Passmore, Peter (2016) A randomised controlled trial of calcium channel blockade (CCB) with amlodipine for the treatment of subcortical ischaemic vascular dementia (AFFECT): study protocol. Trials, 17 (1). ISSN 1745-6215

Gyawali, Bishal and Ferrario, Alessandra and van Teijlingen, Edwin and Kallestrup, Per (2016) Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Global Health Action, 9 (1). ISSN 1654-9716


Hamilton, Zoe and Munger, Anne (2016) Rhetoric vs reality: contraception in India and the DMPA debate. South Asia @ LSE (15 Sep 2016). Blog.

Helfer, Ana Paula and Camargo, Aline Lins and Tavares, Noemia Urruth Leão and Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de Salud Pública / Pan American Journal of Public Health, 31 (3). pp. 225-232. ISSN 1020-4989

Hibberd, Ralph (2016) Accelerating access to new drugs in Japan. Delivering Digital Drugs (11 May 2016). Blog.

Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Blog.

Hibberd, Ralph (2016) Combating falsified medicines in Africa through digital artefacts. Delivering Digital Drugs (27 Sep 2016). Blog.

Hibberd, Ralph (2016) Hub and spoke dispensing: privacy and sociotechnical rigidity. Delivering Digital Drugs (08 Jul 2016). Blog.

Hibberd, Ralph (2016) Hub and spoke dispensing: safety and sociotechnical pliability. Delivering Digital Drugs (07 Jul 2016). Blog.

Hong, Jihyung and Dilla, Tatiana and Arellano, Jorge (2009) A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. BMC Psychiatry, 9 (1). p. 15. ISSN 1471-244X


Izugbara, Chimaraoke O. and Wekesa, Eliud (2011) Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociology of Health and Illness, 33 (6). pp. 869-883. ISSN 0141-9889


Jones, Rob and Sheehan, Bart and Phillips, Patrick and Knapp, Martin (2009) DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease: a multicentre RCT. Trials, 10 (57). ISSN 1745-6215

Juul, Sissel and Nielsen, Christine J. F. and Labouriau, Rodrigo and Roy, Amit and Tesauro, Cinzia and Jensen, Pia W. and Harmsen, Charlotte and Kristoffersen, Emil L. and Chiu, Ya-Ling and Frøhlich, Rikke and Fiorani, Paola and Cox-Singh, Janet and Tordrup, David and Koch, Jørn and Bienvenu, Anne-Lise and Desideri, Alessandro and Picot, Stephane and Petersen, Eskild and Leong, Kam W. and Ho, Yi-Ping and Stougaard, Magnus and Knudsen, Birgitta R. (2012) Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing plasmodium parasites based on enzyme activity measurement. Acs Nano, 6 (12). pp. 10676-10683. ISSN 1936-0851


Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos and Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic Policy, 23 (55). pp. 499-544. ISSN 0266-4658

Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip reports. Scrip, London.

Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705

Kapczynski, Amy and Sampat, Bhaven N. and Shadlen, Kenneth C. (2017) Trade agreements, patents, and drug prices: continuing the debate. Research Paper (572). John M. Olin Center for Studies in Law, Economics, and Public Policy, Yale Law School, New Haven, CT. (Unpublished)

King, Derek and Knapp, Martin and Thomas, P. and Razzouk, D. and Loze, J.-Y. and Kan, H.J. and van Baardewijk, M. (2011) Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current Medical Research and Opinion, 27 (2). pp. 365-374. ISSN 0300-7995

Knapp, Martin and King, Derek and Pugner, Klaus and Lapuerta, Pablo (2004) Non-adherence to antipsychotic medication regimens: associations with resource use and costs. British Journal of Psychiatry, 184 (6). pp. 509-516. ISSN 0007-1250

Knapp, Martin and Locklear, Julie and Jarbrink, Krister (2009) Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Current Medical Research and Opinion, 25 (7). pp. 1593-1603. ISSN 0300-7995

Knapp, Martin and McDaid, David and Park, A-La (2015) Recovery and economics. Die Psychiatrie, 12 (3). pp. 162-166. ISSN 1614-4864

Knapp, Martin and Windmeijer, Frank and Brown, Jacqueline and Kontodimas, Stathis and Tzivelekis, Sypros and Haro, Josep Maria and Ratcliffe, Mark and Hong, Jihyung and Novick, Diego (2008) Cost-utility analysis of treatment with Olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the Pan-European SOHO study. PharmacoEconomics, 26 (4). pp. 341-358. ISSN 1170-7690

Kravdal, Øystein and Grundy, Emily (2014) Underuse of medication for circulatory disorders among unmarried women and men in Norway? BMC Pharmacology and Toxicology, 15 (1). p. 65. ISSN 2050-6511

Kwong, Danica and Ferrario, Alessandra and Adamski, Jajub and Inotai, Andras and Kalo, Zoltan (2014) Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth, 20 (2). pp. 25-28. ISSN 1356-1030


Le Grand, Julian (1997) Afterword. In: Oakley, Ann and Ashton, John, (eds.) The Gift Relationship: From Human Blood to Social Policy. London School of Economics and Political Science, London, UK. ISBN 0753012014

Levin, David and Shiner, Michael (2016) New deviancy theory and the healthcare system's role in creating, labeling, and facilitating unauthorized prescription drug “abuse”. Pain Practice, 16 (7). pp. 791-793. ISSN 1530-7085

Lichtner, Valentina (2016) ‘the little liar’ – patient information about medicines. Delivering Digital Drugs (10 May 2016). Blog.


Malmström, Rickard E. and Godman, Brian B. and Diogene, Eduard and Baumgärtel, Christoph and Bennie, Marion and Bishop, Iain and Brzezinska, Anna and Bucsics, Anna and Campbell, Stephen and Ferrario, Alessandra and Finlayson, Alexander E. and Fürst, Jurij and Garuoliene, Kristina and Gomes, Miguel and Gutiérrez-Ibarluzea, Iñaki and Haycox, Alan and Hviding, Krystyna and Herholz, Harald and Hoffmann, Mikael and Jan, Saira and Jones, Jan and Joppi, Roberta and Kalaba, Marija and Kvalheim, Christina and Laius, Ott and Langner, Irene and Lonsdale, Julie and Lööv, Sven-Äke and Malinowska, Kamila and McCullagh, Laura and Paterson, Ken and Markovic-Pekovic, Vanda and Martin, Andrew and Piessnegger, Jutta and Selke, Gisbert and Sermet, Catherine and Simoens, Steven and Tulunay, Cankat and Tomek, Dominik and Vončina, Luka and Vlahovic-Palcevski, Vera and Wale, Janet and Wilcock, Michael and Wladysiuk, Magdalena and Woerkom, Menno van and Zara, Corrine and Gustafsson, Lars L. (2013) Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4 (39). ISSN 1663-9812

Manfrin, Andrea and Tinelli, Michela and Thomas, Trudy and Krska, Janet (2017) A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Services Research, 17 (300). ISSN 1472-6963

McCrone, Paul R. and Chisholm, Daniel and Knapp, Martin and Hughes, Richard and Comi, Giancarlo and Dalakas, Marinos C. and Illa, Isabel and Kilindireas, Costas and Nobile-Orazio, Eduardo and Swan, Anthony Victor and Van den Bergh, Peter and Willison, Hugh J. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10 (6). pp. 687-694. ISSN 1468-1331

McCrone, Paul R. and Weeramanthri, Tara and Knapp, Martin R.J. and Rushton, Alan and Trowell, Judith and Miles, Gillian and Kolvin, Israel (2005) Cost-effectiveness of individual versus group psychotherapy for sexually abused girls. Child and Adolescent Mental Health, 10 (1). pp. 26-31. ISSN 1475-3588

McGuire, Alistair (2012) The European value-pricing game. Expert Review of Pharmacoeconomics and Outcomes Research, 12 (1). pp. 5-6. ISSN 1473-7167

McGuire, Alistair and Burke, T. and Goldstein, J. and Maniadakis, N. and Pettitt, D. (2000) Overview of the Arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib. British Journal of Rheumatology, 39 (s2). pp. 33-42. ISSN 1462-0324

Morais de Oliveira, Iago (2016) Using international human rights law to guarantee the right to health: a Brazilian experience. LSE Human Rights Blog (13 Dec 2016). Blog.


Naci, Huseyin (2011) The increasing need to harmonize evidence demands of regulators, payers, and health technology assessment bodies in Europe – opportunities and challenges. ISPOR Connections, 17 (4). pp. 4-6. ISSN 1538-5108

Naci, Huseyin and Salcher-Konrad, Maximilian and Dias, Sofia and Blum, Manuel R. and Sahoo, Samali Anova and Nunan, David and Ioannidis, John P. A. (2018) How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 RCTs assessing exercise and medication effects on systolic blood pressure. British Journal of Sports Medicine. ISSN 0306-3674

Naci, Huseyin and van Valkenhoef, G. and Higgins, J. P. T. and Fleurence, R. and Ades, A. E. (2014) Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs. Circulation: Cardiovascular Quality and Outcomes, 7 (5). pp. 787-792. ISSN 1941-7705


O'Neill, Rachel (2014) As if gender mattered: reconsidering the implications of ‘intoxicating stories’. International Journal of Drug Policy, 25 (3). pp. 356-357. ISSN 0955-3959

Owen, Geoffrey (2016) Biotechnology: Why is Europe lagging behind the U.S.? Management with Impact (07 Nov 2016). Blog Entry.


Park, A-La and McDaid, David (2012) Economic modelling of mindfulness meditation for people with mental health problems. In: International Research Congress on Integrative Medicine and Health, 15-18 May 2012, Portland, USA.


Ragan, C. Ian and Bard, Imre and Singh, Ilina (2013) What should we do about student use of cognitive enhancers?: an analysis of current evidence. Neuropharmacology, 64. pp. 588-595. ISSN 0028-3908

Rogeberg, Ole and Bergsvik, Daniel and Phillips, Lawrence D. and Amsterdam, Jan van and Eastwood, Niamh and Henderson, Graeme and Lynskey, Michael and Measham, Fiona and Ponton, Rhys and Rolles, Steve and Schlag, Anne Katrin and Taylor, Polly and Nutt, David (2018) A new approach to formulating and appraising drug policy: a multi-criterion decision analysis applied to alcohol and cannabis regulation. International Journal of Drug Policy. ISSN 0955-3959 (In Press)


Sado, Mitsuhiro and Knapp, Martin and Yamauchi, Keita and Fujisawa, Daisuke and So, Mirai and Nakagawa, Atsuo and Kikuchi, Toshiaki and Ono, Yutaka (2009) Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. Australian and New Zealand Journal of Psychiatry, 43 (6). pp. 539-547. ISSN 0004-8674

Salas-Vega, Sebastian and Iliopoulos, Othon and Mossialos, Elias (2017) Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines. JAMA Oncology, 3 (3). pp. 382-390. ISSN 2374-2437

Shadlen, Kenneth C. (2013) Learning from India? A new approach to secondary pharmaceutical patents. South Asia @ LSE (03 May 2013). Blog.

Shadlen, Kenneth C. and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog.

Shadlen, Kenneth C. and Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. South Asia @ LSE (23 Jul 2012). Blog.

Singh, Ilina (2008) Beyond polemics: science and ethics of ADHD. Nature Reviews Neuroscience, 9 (12). pp. 957-964. ISSN 1471-003X

Sorenson, Corinna and Naci, Huseyin and Cylus, Jonathan and Mossialos, Elias (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal, 343 (7822). d4849-d4849. ISSN 0959-8138

Surguladze, Simon and Patel, Anita and Kerwin, Robert W and Knapp, Martin and Travis, Michael J (2005) Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29 (4). pp. 517-522. ISSN 0278-5846


Tinelli, Michela (2001) Menopausa e terapia ormonale sostitutiva: qualità di vita e farmacoeconomia. Farmacoeconomia News, 3. pp. 15-20. ISSN 1126-4705

Tinelli, Michela (2001) Progetto pilota per la rilevazione delle prescrizioni farmaceutiche in Farmacia. Cronache Farmaceutiche, 4. pp. 200-204. ISSN 0011-1783

Tinelli, Michela and Blenkinsopp, Alison and Bond, Christine (2011) Development, validation and application of a patient satisfaction scale for a community pharmacy medicines-management service. International Journal of Pharmacy Practice, 19 (3). pp. 144-155. ISSN 0961-7671

Towse, A and Drummond, Michael and Sorenson, Corinna (2012) Measuring value: pharmacoeconomics theory and practice. In: Danzon, Patricia M. and Nicholson, Sean, (eds.) Oxford Handbook on the Economics of the Biopharmaceutical Industry. Oxford University Press, Oxford, UK, pp. 394-437. ISBN 9780199742998

Towse, Adrian and Drummond, Michael and Sorenson, Corinna (2011) Measuring value: pharmacoeconomics in theory and practice. Occasional paper (11/03). Office of Health Economics.

Tzouma, Victoria and Grepstad, Mari and Grimaccia, Federico and Kanavos, Panos (2015) Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49 (6). pp. 947-956. ISSN 2168-4790


Vandoros, Sotiris (2014) Therapeutic substitution post-patent expiry: the cases of ace inhibitors and proton pump inhibitors. Health Economics, 23 (5). pp. 621-630. ISSN 1057-9230

Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Vandoros, Sotiris and Stargardt, Tom (2013) Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy, 109 (1). pp. 1-6. ISSN 0168-8510

Varol, Nebibe and Costa-i-Font, Joan and McGuire, Alistair (2012) Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34 (3). pp. 531-553. ISSN 2040-5790

Vermersch, Patrick and Martinelli, Vittorio and Pfleger, Claudia and Rieckmann, Peter and Alonso-Magdalena, Lucia and Galazka, Andrew and Dangond, Fernando and Phillips, Lawrence D. (2019) Benefit-risk assessment of cladribine using multi-criteria decision analysis (MCDA) for patients with relapsing-remitting multiple sclerosis. Clinical Therapeutics. ISSN 0149-2918 (In Press)


Wallach, Joshua D. and Ross, Joseph S. and Naci, Huseyin (2018) The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation. Clinical Trials, 15 (3). pp. 243-246. ISSN 1740-7745

Wekesa, Eliud and Coast, Ernestina (2013) Living with HIV in Kenyan slums in an era of anti-retroviral therapy (ART). Africa at LSE Blog (03 May 2013). Blog Entry.

Williams, Thomas Christie (2017) Long read review: drug dealer, MD: how doctors were duped, patients got hooked and why it’s so hard to stop by Anna Lembke. LSE Review of Books (22 Mar 2017). Blog.

Wouters, Olivier J. and Kanavos, Panos G. and McKee, Martin (2017) Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. Milbank Quarterly, 95 (3). pp. 554-601. ISSN 0887-378X

Wouters, Olivier J. and O'Donoghue, Donal J. and Ritchie, James and Kanavos, Panos G. and Narva, Andrew S. (2015) Early chronic kidney disease: diagnosis, management and models of care. Nature Reviews Nephrology, 11 (8). pp. 491-502. ISSN 1759-5061

This list was generated on Fri Jan 18 10:52:49 2019 GMT.